Search by Drug Name or NDC

NDC 69489-0411-05 Qbrexza 2.4 g/100g Details

Qbrexza 2.4 g/100g

Qbrexza is a TOPICAL CLOTH in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Journey Medical Corporation. The primary component is GLYCOPYRRONIUM TOSYLATE.

MedlinePlus Drug Summary

Topical glycopyrronium is used to treat excessive underarm sweating in adults and children 9 years of age and older. Topical glycopyrronium is in a class of medications called anticholinergics. It works by blocking the activity of a certain natural substance that triggers the sweat glands to produce sweat.

Related Packages: 69489-0411-05
Last Updated: 02/19/2023
MedLinePlus Full Drug Details: Glycopyrronium Topical

Product Information

NDC	69489-0411
Product ID	69489-411_78796126-f6ed-42e3-b40d-ea5723b89516
Associated GPIs	90970030204320
GCN Sequence Number	078624
GCN Sequence Number Description	glycopyrronium tosylate TOWELETTE 2.4 % TOPICAL
HIC3	L8C
HIC3 Description	TOPICAL ANTICHOLINERGIC HYPERHIDROSIS TX AGENTS
GCN	44983
HICL Sequence Number	045086
HICL Sequence Number Description	GLYCOPYRRONIUM TOSYLATE
Brand/Generic	Brand
Proprietary Name	Qbrexza
Proprietary Name Suffix	n/a
Non-Proprietary Name	glycopyrronium
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	CLOTH
Route	TOPICAL
Active Ingredient Strength	2.4
Active Ingredient Units	g/100g
Substance Name	GLYCOPYRRONIUM TOSYLATE
Labeler Name	Journey Medical Corporation
Pharmaceutical Class	Anticholinergic [EPC], Cholinergic Antagonists [MoA], Cholinergic Muscarinic Antagonist [EPC], Cholinergic Muscarinic Antagonists [MoA]
DEA Schedule	n/a
Marketing Category	NDA
Application Number	NDA210361
Listing Certified Through	2024-12-31

Package

NDC 69489-0411-05 (69489041105)

Pricing Information	N/A
NDC Package Code	69489-411-05
Billing NDC	69489041105
Package	5 POUCH in 1 CARTON (69489-411-05) / 2.8 g in 1 POUCH (69489-411-51)
Marketing Start Date	2021-12-03
NDC Exclude Flag	N